Open access
Oct 2026
Apixaban for thromboprophylaxis in paediatric cardiology patients: Real-world data from a single institution.
BACKGROUND Thrombosis is a major complication in children with congenital or acquired heart disease, contributing to significant morbidity and mortality. Direct oral anticoagulants (DOACs), including apixaban, are increasingly used for thromboprophylaxis in this population yet real-world paediatric data remain limited....
Alessandra Bosch, F. Berger, Hitendu N. Dave et al.
· Thrombosis Research · 0 citations